Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zeruesenay Desta

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Drug Metabolism and Pharmacokinetics|February 7, 2013
In vitro analysis and quantitative prediction of efavirenz inhibition of eight cytochrome P450 (CYP) enzymes: major effects on CYPs 2B6, 2C8, 2C9 and 2C19Cong Xu, Zeruesenay Desta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Germline pharmacogenetics of tamoxifen response: have we learned enough?Zeruesenay Desta, David A Flockhart
Clinical Pharmacology and Therapeutics|February 24, 2018
CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. FlockhartTodd C Skaar, Zeruesenay Desta
British Journal of Clinical Pharmacology|February 9, 2016
Obituary: David Alastair Flockhart , MD, PhDRobert Bies, Christine McDonald, Zeruesenay Desta
Journal of Clinical Psychopharmacology|March 23, 2002
In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycinZeruesenay Desta, Nadia Soukhova, David A Flockhart
Antimicrobial Agents and Chemotherapy|November 26, 2008
Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3ASeongwook Jeong, Phuong D Nguyen, Zeruesenay Desta
AIDS (London, England)|January 6, 2025
The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysisSamir K Gupta, Allon N Friedman, Zeruesenay Desta
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 5, 2022
Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and IntestineNadia O Bamfo, Jessica Bl Lu, Zeruesenay Desta
Breast Cancer Research and Treatment|March 11, 2011
Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancerWenjie Jessie Lu, Zeruesenay Desta, David A Flockhart
Statistics in Medicine|August 19, 2004
QT analysis: a complex answer to a 'simple' problemLang Li, Mehul Desai, Zeruesenay Desta, et al.
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Drug Metabolism and Pharmacokinetics|February 7, 2013
In vitro analysis and quantitative prediction of efavirenz inhibition of eight cytochrome P450 (CYP) enzymes: major effects on CYPs 2B6, 2C8, 2C9 and 2C19Cong Xu, Zeruesenay Desta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 21, 2007
Germline pharmacogenetics of tamoxifen response: have we learned enough?Zeruesenay Desta, David A Flockhart
Clinical Pharmacology and Therapeutics|February 24, 2018
CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. FlockhartTodd C Skaar, Zeruesenay Desta
British Journal of Clinical Pharmacology|February 9, 2016
Obituary: David Alastair Flockhart , MD, PhDRobert Bies, Christine McDonald, Zeruesenay Desta
Journal of Clinical Psychopharmacology|March 23, 2002
In vitro inhibition of pimozide N-dealkylation by selective serotonin reuptake inhibitors and azithromycinZeruesenay Desta, Nadia Soukhova, David A Flockhart
Antimicrobial Agents and Chemotherapy|November 26, 2008
Comprehensive in vitro analysis of voriconazole inhibition of eight cytochrome P450 (CYP) enzymes: major effect on CYPs 2B6, 2C9, 2C19, and 3ASeongwook Jeong, Phuong D Nguyen, Zeruesenay Desta
AIDS (London, England)|January 6, 2025
The steady-state pharmacokinetics of fixed-dose combination dolutegravir+rilpivirine in hemodialysisSamir K Gupta, Allon N Friedman, Zeruesenay Desta
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 5, 2022
Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and IntestineNadia O Bamfo, Jessica Bl Lu, Zeruesenay Desta
Breast Cancer Research and Treatment|March 11, 2011
Tamoxifen metabolites as active inhibitors of aromatase in the treatment of breast cancerWenjie Jessie Lu, Zeruesenay Desta, David A Flockhart
Statistics in Medicine|August 19, 2004
QT analysis: a complex answer to a 'simple' problemLang Li, Mehul Desai, Zeruesenay Desta, et al.
Pageof 14